Abstract PD3-11: A randomized, open-label, phase III trial of pertuzumab re-treatment in HER2-positive, locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab, and chemotherapy: The Japan Breast Cancer Research Group-M05 (PRECIOUS) study
Keyword(s):
2018 ◽
Vol 48
(9)
◽
pp. 855-859
◽
Keyword(s):
2016 ◽
Vol 34
(15_suppl)
◽
pp. TPS636-TPS636
Keyword(s):
Keyword(s):
Keyword(s):
2019 ◽
Keyword(s):
2012 ◽
Keyword(s):